Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.98 in the prior trading day, Mersana Therapeutics Inc (NASDAQ: MRSN) closed at $2.04, up 3.03%. In other words, the price has increased by $3.03 from its previous closing price. On the day, 0.59 million shares were traded. MRSN stock price reached its highest trading level at $2.115 during the session, while it also had its lowest trading level at $1.9507.
Ratios:
Our goal is to gain a better understanding of MRSN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.35 and its Current Ratio is at 2.35. In the meantime, Its Debt-to-Equity ratio is 30.00 whereas as Long-Term Debt/Eq ratio is at 15.51.
On March 19, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $5.
Wedbush Upgraded its Neutral to Outperform on February 29, 2024, whereas the target price for the stock was revised from $2 to $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 28 ’24 when Bala Mohan sold 1,884 shares for $1.90 per share. The transaction valued at 3,580 led to the insider holds 54,731 shares of the business.
Bala, Mohan bought 1,884 shares of MRSN for $3,843 on Oct 28 ’24. On Oct 02 ’24, another insider, DeSchuytner Brian, who serves as the SVP, COO & CFO of the company, sold 8,089 shares for $2.00 each. As a result, the insider received 16,178 and left with 100,422 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 252007312. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.45 while its Price-to-Book (P/B) ratio in mrq is 238.88.
Stock Price History:
Over the past 52 weeks, MRSN has reached a high of $6.28, while it has fallen to a 52-week low of $1.22. The 50-Day Moving Average of the stock is -1.44%, while the 200-Day Moving Average is calculated to be -24.04%.
Shares Statistics:
The stock has traded on average 1.02M shares per day over the past 3-months and 1289110 shares per day over the last 10 days, according to various share statistics. A total of 120.71M shares are outstanding, with a floating share count of 86.30M. Insiders hold about 30.14% of the company’s shares, while institutions hold 66.05% stake in the company. Shares short for MRSN as of 1730332800 were 9872200 with a Short Ratio of 9.69, compared to 1727654400 on 9531634. Therefore, it implies a Short% of Shares Outstanding of 9872200 and a Short% of Float of 10.58.
